Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine SuccinylationZhuomeng Zheng, Xiyun Deng, Li Zhou et al.|Journal of Cancer|2024Cited by 8
Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of LovastatinChanjuan Zheng, Xiyun Deng, Hui Yao et al.|International Journal of Biological Sciences|2024Cited by 7
Filamentous Actin in the Nucleus in Triple-Negative Breast Cancer Stem Cells: A Key to Drug-Induced Nucleolar Stress and Stemness Inhibition?Xinyu Wang, Xiyun Deng, Chanjuan Zheng et al.|Journal of Cancer|2024Cited by 2
Lovastatin Targets the USP14–Survivin Axis to Suppress Triple-Negative Breast Cancer via Ubiquitin-Mediated Proteasomal DegradationLi Zhou, Xiyun Deng, Chanjuan Zheng et al.|Cells|2025Cited by 2